Recall Register

Food, drugs, devices › Neocis, Inc.

Device recall: DRW-0739-01:Gen 2 Anterior Chairside Splint LRUL (lower right-upper left); accessories to the parent system, the Neocis

FDA enforcement event 87060 · Class II · initiated 30 Oct 2020 · status Terminated · terminated 11 Aug 2021

DeviceVoluntary: Firm initiated1 product recordMiami, FL

Neocis, Inc. (Miami, FL) initiated this device recall on 30 Oct 2020; FDA lists 1 product record under event 87060, classified Class II.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 93% of the 916 device enforcement events initiated in 2020 carry the same class.

Status: Terminated, terminated 11 Aug 2021. Initiation: voluntary: firm initiated. Neocis, Inc. has 3 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Neocis, Inc., Miami, FL.

Reason for recall

"The LRUL and LLUR posterior chairside splints and the LLUR anterior chairside splints may be mislabeled."

Distribution

"OH, FL, CT, MA, AZ PA, NY"

Product records

Recall numberProductQuantityClassStatusReport date
Z-0929-2021DRW-0739-01:Gen 2 Anterior Chairside Splint LRUL (lower right-upper left); accessories to the parent system, the Neocis Guidance System (NGS)100 unitsClass IITerminated3 Feb 2021

Context

93%of 2020 device events are Class II916 events that year
1product record in this eventfirm median: 1
3events on this register for the firm

Other enforcement events for Neocis, Inc.

InitiatedProduct (first record)TypeClassRecords
14 May 2020DRW-0739-01: Gen 2 Posterior Chairside Splint LLUR (lower left-upper right) - Product Usage: intended to provide assistaDeviceClass II3
4 Oct 2019Neocis Guidance System Fiducial Array - Product Usage: The Neocis Guidance System (NGS) is a computerized navigational sDeviceClass II1

All 3 events for Neocis, Inc.

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "The LRUL and LLUR posterior chairside splints and the LLUR anterior chairside splints may be mislabeled."

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "OH, FL, CT, MA, AZ PA, NY"

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 11 Aug 2021. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.